Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma

Baldeep Wirk, Timothy S. Fenske, Mehdi Hamadani, Mei Jie Zhang, Zhen Huan Hu, Görgün Akpek, Mahmoud D. Aljurf, Philippe Armand, Ernesto Ayala, Veronika Bachanova, Brian Bolwell, Mitchell S. Cairo, Amanda Cashen, Yi Bin Chen, Luciano J. Costa, Shatha Farhan, César O. Freytes, James L. Gajewski, John Gibson, Gregory A. Hale & 21 others Leona A. Holmberg, Jack W. Hsu, David J. Inwards, Rummurti T. Kamble, Dipnarine Maharaj, Richard Maziarz, Reinhold Munker, Rajneesh Nath, Nishitha M. Reddy, Craig B. Reeder, David A. Rizzieri, Craig S. Sauter, Bipin N. Savani, Harry C. Schouten, Anna Sureda, Julie M. Vose, Edmund K. Waller, Peter H. Wiernik, Robert Peter Gale, Linda J. Burns, Wael Saber

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

There are limited data on the outcomes of autologous or allogeneic hematopoietic cell transplantation (HCT) in diffuse large B cell lymphoma transformed from follicular lymphoma. We analyzed transplantation outcomes in 141 subjects with biopsy-proven diffuse large B-cell lymphoma transformed from follicular lymphoma reported to the Center for International Blood and Marrow Transplant Research between 1990 and 2009. Two groups were identified: autologous HCT (auto-HCT; n = 108) and allogeneic HCT (allo-HCT; n = 33). Fewer auto-HCTs were done for transformed follicular lymphoma in 2003 to 2009, with a shift favoring allo-HCT. Auto-HCT was associated with a 1-year nonrelapse mortality (NRM) of 8% (95% confidence interval [CI], 4% to 14%), 5-year progression-free survival of 35% (95% CI, 26% to 45%), and 5-year overall survival of 50% (95% CI, 40% to 59%). In contrast, allo-HCT was associated with a 1-year NRM of 41% (95% CI, 23% to 58%), 5-year progression-free survival of 18% (95% CI, 6% to 35%), and 5-year overall survival of 22% (95% CI, 8% to 41%). Auto-HCT for transformed follicular lymphoma achieves sustained remission in a high proportion of subjects. The high NRM of allo-HCT offset any benefit that might be associated with this transplantation modality.

Original languageEnglish (US)
Pages (from-to)951-959
Number of pages9
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Cell Transplantation
Confidence Intervals
Disease-Free Survival
Mortality
Transplantation
Bone Marrow
Transplants
Biopsy

Keywords

  • Transformed follicular lymphoma
  • Transplant

ASJC Scopus subject areas

  • Transplantation
  • Hematology
  • Medicine(all)

Cite this

Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma. / Wirk, Baldeep; Fenske, Timothy S.; Hamadani, Mehdi; Zhang, Mei Jie; Hu, Zhen Huan; Akpek, Görgün; Aljurf, Mahmoud D.; Armand, Philippe; Ayala, Ernesto; Bachanova, Veronika; Bolwell, Brian; Cairo, Mitchell S.; Cashen, Amanda; Chen, Yi Bin; Costa, Luciano J.; Farhan, Shatha; Freytes, César O.; Gajewski, James L.; Gibson, John; Hale, Gregory A.; Holmberg, Leona A.; Hsu, Jack W.; Inwards, David J.; Kamble, Rummurti T.; Maharaj, Dipnarine; Maziarz, Richard; Munker, Reinhold; Nath, Rajneesh; Reddy, Nishitha M.; Reeder, Craig B.; Rizzieri, David A.; Sauter, Craig S.; Savani, Bipin N.; Schouten, Harry C.; Sureda, Anna; Vose, Julie M.; Waller, Edmund K.; Wiernik, Peter H.; Gale, Robert Peter; Burns, Linda J.; Saber, Wael.

In: Biology of Blood and Marrow Transplantation, Vol. 20, No. 7, 2014, p. 951-959.

Research output: Contribution to journalArticle

Wirk, B, Fenske, TS, Hamadani, M, Zhang, MJ, Hu, ZH, Akpek, G, Aljurf, MD, Armand, P, Ayala, E, Bachanova, V, Bolwell, B, Cairo, MS, Cashen, A, Chen, YB, Costa, LJ, Farhan, S, Freytes, CO, Gajewski, JL, Gibson, J, Hale, GA, Holmberg, LA, Hsu, JW, Inwards, DJ, Kamble, RT, Maharaj, D, Maziarz, R, Munker, R, Nath, R, Reddy, NM, Reeder, CB, Rizzieri, DA, Sauter, CS, Savani, BN, Schouten, HC, Sureda, A, Vose, JM, Waller, EK, Wiernik, PH, Gale, RP, Burns, LJ & Saber, W 2014, 'Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma', Biology of Blood and Marrow Transplantation, vol. 20, no. 7, pp. 951-959. https://doi.org/10.1016/j.bbmt.2014.03.014
Wirk, Baldeep ; Fenske, Timothy S. ; Hamadani, Mehdi ; Zhang, Mei Jie ; Hu, Zhen Huan ; Akpek, Görgün ; Aljurf, Mahmoud D. ; Armand, Philippe ; Ayala, Ernesto ; Bachanova, Veronika ; Bolwell, Brian ; Cairo, Mitchell S. ; Cashen, Amanda ; Chen, Yi Bin ; Costa, Luciano J. ; Farhan, Shatha ; Freytes, César O. ; Gajewski, James L. ; Gibson, John ; Hale, Gregory A. ; Holmberg, Leona A. ; Hsu, Jack W. ; Inwards, David J. ; Kamble, Rummurti T. ; Maharaj, Dipnarine ; Maziarz, Richard ; Munker, Reinhold ; Nath, Rajneesh ; Reddy, Nishitha M. ; Reeder, Craig B. ; Rizzieri, David A. ; Sauter, Craig S. ; Savani, Bipin N. ; Schouten, Harry C. ; Sureda, Anna ; Vose, Julie M. ; Waller, Edmund K. ; Wiernik, Peter H. ; Gale, Robert Peter ; Burns, Linda J. ; Saber, Wael. / Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma. In: Biology of Blood and Marrow Transplantation. 2014 ; Vol. 20, No. 7. pp. 951-959.
@article{b108bf2ab7d34010ba5e93085b86fceb,
title = "Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma",
abstract = "There are limited data on the outcomes of autologous or allogeneic hematopoietic cell transplantation (HCT) in diffuse large B cell lymphoma transformed from follicular lymphoma. We analyzed transplantation outcomes in 141 subjects with biopsy-proven diffuse large B-cell lymphoma transformed from follicular lymphoma reported to the Center for International Blood and Marrow Transplant Research between 1990 and 2009. Two groups were identified: autologous HCT (auto-HCT; n = 108) and allogeneic HCT (allo-HCT; n = 33). Fewer auto-HCTs were done for transformed follicular lymphoma in 2003 to 2009, with a shift favoring allo-HCT. Auto-HCT was associated with a 1-year nonrelapse mortality (NRM) of 8{\%} (95{\%} confidence interval [CI], 4{\%} to 14{\%}), 5-year progression-free survival of 35{\%} (95{\%} CI, 26{\%} to 45{\%}), and 5-year overall survival of 50{\%} (95{\%} CI, 40{\%} to 59{\%}). In contrast, allo-HCT was associated with a 1-year NRM of 41{\%} (95{\%} CI, 23{\%} to 58{\%}), 5-year progression-free survival of 18{\%} (95{\%} CI, 6{\%} to 35{\%}), and 5-year overall survival of 22{\%} (95{\%} CI, 8{\%} to 41{\%}). Auto-HCT for transformed follicular lymphoma achieves sustained remission in a high proportion of subjects. The high NRM of allo-HCT offset any benefit that might be associated with this transplantation modality.",
keywords = "Transformed follicular lymphoma, Transplant",
author = "Baldeep Wirk and Fenske, {Timothy S.} and Mehdi Hamadani and Zhang, {Mei Jie} and Hu, {Zhen Huan} and G{\"o}rg{\"u}n Akpek and Aljurf, {Mahmoud D.} and Philippe Armand and Ernesto Ayala and Veronika Bachanova and Brian Bolwell and Cairo, {Mitchell S.} and Amanda Cashen and Chen, {Yi Bin} and Costa, {Luciano J.} and Shatha Farhan and Freytes, {C{\'e}sar O.} and Gajewski, {James L.} and John Gibson and Hale, {Gregory A.} and Holmberg, {Leona A.} and Hsu, {Jack W.} and Inwards, {David J.} and Kamble, {Rummurti T.} and Dipnarine Maharaj and Richard Maziarz and Reinhold Munker and Rajneesh Nath and Reddy, {Nishitha M.} and Reeder, {Craig B.} and Rizzieri, {David A.} and Sauter, {Craig S.} and Savani, {Bipin N.} and Schouten, {Harry C.} and Anna Sureda and Vose, {Julie M.} and Waller, {Edmund K.} and Wiernik, {Peter H.} and Gale, {Robert Peter} and Burns, {Linda J.} and Wael Saber",
year = "2014",
doi = "10.1016/j.bbmt.2014.03.014",
language = "English (US)",
volume = "20",
pages = "951--959",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma

AU - Wirk, Baldeep

AU - Fenske, Timothy S.

AU - Hamadani, Mehdi

AU - Zhang, Mei Jie

AU - Hu, Zhen Huan

AU - Akpek, Görgün

AU - Aljurf, Mahmoud D.

AU - Armand, Philippe

AU - Ayala, Ernesto

AU - Bachanova, Veronika

AU - Bolwell, Brian

AU - Cairo, Mitchell S.

AU - Cashen, Amanda

AU - Chen, Yi Bin

AU - Costa, Luciano J.

AU - Farhan, Shatha

AU - Freytes, César O.

AU - Gajewski, James L.

AU - Gibson, John

AU - Hale, Gregory A.

AU - Holmberg, Leona A.

AU - Hsu, Jack W.

AU - Inwards, David J.

AU - Kamble, Rummurti T.

AU - Maharaj, Dipnarine

AU - Maziarz, Richard

AU - Munker, Reinhold

AU - Nath, Rajneesh

AU - Reddy, Nishitha M.

AU - Reeder, Craig B.

AU - Rizzieri, David A.

AU - Sauter, Craig S.

AU - Savani, Bipin N.

AU - Schouten, Harry C.

AU - Sureda, Anna

AU - Vose, Julie M.

AU - Waller, Edmund K.

AU - Wiernik, Peter H.

AU - Gale, Robert Peter

AU - Burns, Linda J.

AU - Saber, Wael

PY - 2014

Y1 - 2014

N2 - There are limited data on the outcomes of autologous or allogeneic hematopoietic cell transplantation (HCT) in diffuse large B cell lymphoma transformed from follicular lymphoma. We analyzed transplantation outcomes in 141 subjects with biopsy-proven diffuse large B-cell lymphoma transformed from follicular lymphoma reported to the Center for International Blood and Marrow Transplant Research between 1990 and 2009. Two groups were identified: autologous HCT (auto-HCT; n = 108) and allogeneic HCT (allo-HCT; n = 33). Fewer auto-HCTs were done for transformed follicular lymphoma in 2003 to 2009, with a shift favoring allo-HCT. Auto-HCT was associated with a 1-year nonrelapse mortality (NRM) of 8% (95% confidence interval [CI], 4% to 14%), 5-year progression-free survival of 35% (95% CI, 26% to 45%), and 5-year overall survival of 50% (95% CI, 40% to 59%). In contrast, allo-HCT was associated with a 1-year NRM of 41% (95% CI, 23% to 58%), 5-year progression-free survival of 18% (95% CI, 6% to 35%), and 5-year overall survival of 22% (95% CI, 8% to 41%). Auto-HCT for transformed follicular lymphoma achieves sustained remission in a high proportion of subjects. The high NRM of allo-HCT offset any benefit that might be associated with this transplantation modality.

AB - There are limited data on the outcomes of autologous or allogeneic hematopoietic cell transplantation (HCT) in diffuse large B cell lymphoma transformed from follicular lymphoma. We analyzed transplantation outcomes in 141 subjects with biopsy-proven diffuse large B-cell lymphoma transformed from follicular lymphoma reported to the Center for International Blood and Marrow Transplant Research between 1990 and 2009. Two groups were identified: autologous HCT (auto-HCT; n = 108) and allogeneic HCT (allo-HCT; n = 33). Fewer auto-HCTs were done for transformed follicular lymphoma in 2003 to 2009, with a shift favoring allo-HCT. Auto-HCT was associated with a 1-year nonrelapse mortality (NRM) of 8% (95% confidence interval [CI], 4% to 14%), 5-year progression-free survival of 35% (95% CI, 26% to 45%), and 5-year overall survival of 50% (95% CI, 40% to 59%). In contrast, allo-HCT was associated with a 1-year NRM of 41% (95% CI, 23% to 58%), 5-year progression-free survival of 18% (95% CI, 6% to 35%), and 5-year overall survival of 22% (95% CI, 8% to 41%). Auto-HCT for transformed follicular lymphoma achieves sustained remission in a high proportion of subjects. The high NRM of allo-HCT offset any benefit that might be associated with this transplantation modality.

KW - Transformed follicular lymphoma

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=84902084890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902084890&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2014.03.014

DO - 10.1016/j.bbmt.2014.03.014

M3 - Article

VL - 20

SP - 951

EP - 959

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 7

ER -